Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 188

1.

The regenerating family member 3 β instigates IL-17A-mediated neutrophil recruitment downstream of NOD1/2 signalling for controlling colonisation resistance independently of microbiota community structure.

Waldschmitt N, Kitamoto S, Secher T, Zacharioudaki V, Boulard O, Floquet E, Delacre M, Lamas B, Pham HP, Six A, Richard ML, Dagorn JC, Eberl G, Langella P, Chatel JM, Ryffel B, Iovanna JL, Poulin LF, Sokol H, Kamada N, Chamaillard M.

Gut. 2019 Jul;68(7):1190-1199. doi: 10.1136/gutjnl-2018-316757. Epub 2018 Oct 2.

PMID:
30279238
2.

BTN3A is a prognosis marker and a promising target for Vγ9Vδ2 T cells based-immunotherapy in pancreatic ductal adenocarcinoma (PDAC).

Benyamine A, Loncle C, Foucher E, Blazquez JL, Castanier C, Chrétien AS, Modesti M, Secq V, Chouaib S, Gironella M, Vila-Navarro E, Montalto G, Dagorn JC, Dusetti N, Iovanna J, Olive D.

Oncoimmunology. 2017 Sep 21;7(1):e1372080. doi: 10.1080/2162402X.2017.1372080. eCollection 2017.

3.

[Medico-economic impact of an innovative management of CHF by HF unit].

Baudouin C, Groshens S, Gueneau P, Rousseau M, Saura M, Hryschyschyn N, Hillani A, Dagorn J, Pitthan E, Jourdain P.

Ann Cardiol Angeiol (Paris). 2015 Nov;64(5):318-24. doi: 10.1016/j.ancard.2015.09.036. Epub 2015 Oct 21. French.

PMID:
26482635
4.

Germline copy number variation in the YTHDC2 gene: does it have a role in finding a novel potential molecular target involved in pancreatic adenocarcinoma susceptibility?

Fanale D, Iovanna JL, Calvo EL, Berthezene P, Belleau P, Dagorn JC, Bronte G, Cicero G, Bazan V, Rolfo C, Santini D, Russo A.

Expert Opin Ther Targets. 2014 Aug;18(8):841-50. doi: 10.1517/14728222.2014.920324. Epub 2014 May 16.

PMID:
24834797
5.

Neonatal screening for cystic fibrosis: comparing the performances of IRT/DNA and IRT/PAP.

Sarles J, Giorgi R, Berthézène P, Munck A, Cheillan D, Dagorn JC, Roussey M.

J Cyst Fibros. 2014 Jul;13(4):384-90. doi: 10.1016/j.jcf.2014.01.004. Epub 2014 Feb 7.

6.

Pancreatitis-associated protein does not predict disease relapse in inflammatory bowel disease patients.

Nunes T, Etchevers MJ, Sandi MJ, Pinó Donnay S, Grandjean T, Pellisé M, Panés J, Ricart E, Iovanna JL, Dagorn JC, Chamaillard M, Sans M.

PLoS One. 2014 Jan 9;9(1):e84957. doi: 10.1371/journal.pone.0084957. eCollection 2014.

7.

Analysis of germline gene copy number variants of patients with sporadic pancreatic adenocarcinoma reveals specific variations.

Fanale D, Iovanna JL, Calvo EL, Berthezene P, Belleau P, Dagorn JC, Ancona C, Catania G, D'Alia P, Galvano A, Gulotta E, Lo Dico S, Passiglia F, Bronte G, Midiri M, Lo Re G, Cicero G, Bazan V, Russo A.

Oncology. 2013;85(5):306-11. doi: 10.1159/000354737. Epub 2013 Nov 9.

PMID:
24217364
8.

Usefulness of pancreatitis-associated protein, a novel biomarker, to predict severity of disease in ambulatory patients with heart failure.

Fitzgibbons TP, Paolino J, Dagorn JC, Meyer TE.

Am J Cardiol. 2014 Jan 1;113(1):123-6. doi: 10.1016/j.amjcard.2013.09.026. Epub 2013 Oct 3.

PMID:
24188888
9.

NUPR1 works against the metabolic stress-induced autophagy-associated cell death in pancreatic cancer cells.

Hamidi T, Cano CE, Grasso D, Garcia MN, Sandi MJ, Calvo EL, Dagorn JC, Lomberk G, Goruppi S, Urrutia R, Carracedo A, Velasco G, Iovanna JL.

Autophagy. 2013 Jan;9(1):95-7. doi: 10.4161/auto.22258. Epub 2012 Oct 9.

10.

Nupr1-aurora kinase A pathway provides protection against metabolic stress-mediated autophagic-associated cell death.

Hamidi T, Cano CE, Grasso D, Garcia MN, Sandi MJ, Calvo EL, Dagorn JC, Lomberk G, Urrutia R, Goruppi S, Carracedo A, Velasco G, Iovanna JL.

Clin Cancer Res. 2012 Oct 1;18(19):5234-46. doi: 10.1158/1078-0432.CCR-12-0026. Epub 2012 Aug 16.

11.

Current knowledge on pancreatic cancer.

Iovanna J, Mallmann MC, Gonçalves A, Turrini O, Dagorn JC.

Front Oncol. 2012 Jan 31;2:6. doi: 10.3389/fonc.2012.00006. eCollection 2012.

12.

Nuclear protein 1 promotes pancreatic cancer development and protects cells from stress by inhibiting apoptosis.

Hamidi T, Algül H, Cano CE, Sandi MJ, Molejon MI, Riemann M, Calvo EL, Lomberk G, Dagorn JC, Weih F, Urrutia R, Schmid RM, Iovanna JL.

J Clin Invest. 2012 Jun;122(6):2092-103. doi: 10.1172/JCI60144. Epub 2012 May 8.

13.

p8 expression controls pancreatic cancer cell migration, invasion, adhesion, and tumorigenesis.

Sandi MJ, Hamidi T, Malicet C, Cano C, Loncle C, Pierres A, Dagorn JC, Iovanna JL.

J Cell Physiol. 2011 Dec;226(12):3442-51. doi: 10.1002/jcp.22702.

PMID:
21344397
14.

A review of kinases implicated in pancreatic cancer.

Giroux V, Dagorn JC, Iovanna JL.

Pancreatology. 2009;9(6):738-54. doi: 10.1159/000199435. Epub 2010 Jan 15. Review.

PMID:
20090395
15.

[Therapeutic education of heart failure patients in France].

Jourdain P, Juillière Y, Boireau A, Bellorini M, Desnos M, Dagorn J, Funck F.

Presse Med. 2009 Dec;38(12):1797-804. doi: 10.1016/j.lpm.2009.09.005. Epub 2009 Nov 17. French.

PMID:
19926440
16.

The reg4 gene, amplified in the early stages of pancreatic cancer development, is a promising therapeutic target.

Legoffic A, Calvo E, Cano C, Folch-Puy E, Barthet M, Delpero JR, Ferrés-Masó M, Dagorn JC, Closa D, Iovanna J.

PLoS One. 2009 Oct 16;4(10):e7495. doi: 10.1371/journal.pone.0007495.

17.

Genetic alterations in precancerous pancreatic lesions and their clinical implications.

Turrini O, Cano C, Legoffic A, Delpero JR, Dagorn JC, Iovanna J.

Gastroenterol Clin Biol. 2009 Oct-Nov;33(10-11):1028-35, e1-9. doi: 10.1016/j.gcb.2009.08.007. Epub 2009 Sep 18. English, French.

18.

p8/nupr1 regulates DNA-repair activity after double-strand gamma irradiation-induced DNA damage.

Gironella M, Malicet C, Cano C, Sandi MJ, Hamidi T, Tauil RM, Baston M, Valaco P, Moreno S, Lopez F, Neira JL, Dagorn JC, Iovanna JL.

J Cell Physiol. 2009 Dec;221(3):594-602. doi: 10.1002/jcp.21889.

PMID:
19650074
19.

PAP1 signaling involves MAPK signal transduction.

Ferrés-Masó M, Sacilotto N, López-Rodas G, Dagorn JC, Iovanna JL, Closa D, Folch-Puy E.

Cell Mol Life Sci. 2009 Jul;66(13):2195-204. doi: 10.1007/s00018-009-0040-4. Epub 2009 May 12.

20.

Identification of genomic alterations associated with the aggressiveness of pancreatic cancer using an ultra-high-resolution CGH array.

Legoffic A, Calvo EL, Barthet M, Delpero JR, Dagorn JC, Iovanna JL.

Pancreatology. 2009;9(3):267-72. doi: 10.1159/000212092. Epub 2009 Apr 29.

PMID:
19407481
21.

Combined inhibition of PAK7, MAP3K7 and CK2alpha kinases inhibits the growth of MiaPaCa2 pancreatic cancer cell xenografts.

Giroux V, Iovanna JL, Garcia S, Dagorn JC.

Cancer Gene Ther. 2009 Sep;16(9):731-40. doi: 10.1038/cgt.2009.22. Epub 2009 Apr 10.

PMID:
19363471
22.

Toll-like receptor 2 is critical for induction of Reg3 beta expression and intestinal clearance of Yersinia pseudotuberculosis.

Dessein R, Gironella M, Vignal C, Peyrin-Biroulet L, Sokol H, Secher T, Lacas-Gervais S, Gratadoux JJ, Lafont F, Dagorn JC, Ryffel B, Akira S, Langella P, Nùñez G, Sirard JC, Iovanna J, Simonet M, Chamaillard M.

Gut. 2009 Jun;58(6):771-6. doi: 10.1136/gut.2008.168443. Epub 2009 Jan 27.

PMID:
19174417
23.

MicroRNAs in pancreatic ductal adenocarcinoma: new diagnostic and therapeutic clues.

Seux M, Iovanna J, Dagorn JC, Dusetti NJ.

Pancreatology. 2009;9(1-2):66-72. doi: 10.1159/000178876. Epub 2008 Dec 12. Review.

PMID:
19077456
24.

The TP53INP2 protein is required for autophagy in mammalian cells.

Nowak J, Archange C, Tardivel-Lacombe J, Pontarotti P, Pébusque MJ, Vaccaro MI, Velasco G, Dagorn JC, Iovanna JL.

Mol Biol Cell. 2009 Feb;20(3):870-81. doi: 10.1091/mbc.E08-07-0671. Epub 2008 Dec 3.

25.

Characterisation of peripartum cardiomyopathy by cardiac magnetic resonance imaging.

Mouquet F, Lions C, de Groote P, Bouabdallaoui N, Willoteaux S, Dagorn J, Deruelle P, Lamblin N, Bauters C, Beregi JP.

Eur Radiol. 2008 Dec;18(12):2765-9. doi: 10.1007/s00330-008-1067-x. Epub 2008 Jul 19.

PMID:
18642002
26.

The WSB1 gene is involved in pancreatic cancer progression.

Archange C, Nowak J, Garcia S, Moutardier V, Calvo EL, Dagorn JC, Iovanna JL.

PLoS One. 2008 Jun 25;3(6):e2475. doi: 10.1371/journal.pone.0002475.

27.

Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development.

Gironella M, Seux M, Xie MJ, Cano C, Tomasini R, Gommeaux J, Garcia S, Nowak J, Yeung ML, Jeang KT, Chaix A, Fazli L, Motoo Y, Wang Q, Rocchi P, Russo A, Gleave M, Dagorn JC, Iovanna JL, Carrier A, Pébusque MJ, Dusetti NJ.

Proc Natl Acad Sci U S A. 2007 Oct 9;104(41):16170-5. Epub 2007 Oct 2.

28.

The effects of beta-blockers in patients with stable chronic heart failure. Predictors of left ventricular ejection fraction improvement and impact on prognosis.

de Groote P, Delour P, Mouquet F, Lamblin N, Dagorn J, Hennebert O, Le Tourneau T, Foucher-Hossein C, Verkindère C, Bauters C.

Am Heart J. 2007 Sep;154(3):589-95.

PMID:
17719311
29.

Is hyperlipasemia in critically ill patients of clinical importance? An observational CT study.

Denz C, Siegel L, Lehmann KJ, Dagorn JC, Fiedler F.

Intensive Care Med. 2007 Sep;33(9):1633-6. Epub 2007 May 12.

PMID:
17497124
30.

Experimental acute pancreatitis in PAP/HIP knock-out mice.

Gironella M, Folch-Puy E, LeGoffic A, Garcia S, Christa L, Smith A, Tebar L, Hunt SP, Bayne R, Smith AJ, Dagorn JC, Closa D, Iovanna JL.

Gut. 2007 Aug;56(8):1091-7. Epub 2007 Apr 4.

31.

Acute heart failure associated with venlafaxine poisoning.

Fangio P, De Jonghe B, Appéré-De-Vecchi C, Lachérade JC, Terville JP, Outin H, Dagorn J.

Am J Emerg Med. 2007 Feb;25(2):210-1. No abstract available.

PMID:
17276818
32.
33.

Myocardial metastasis of a bronchial carcinoid.

Maréchaux S, Dagorn J, Gaxotte V, Ennezat PV, Beregi JP, Bauters C, Deklunder G, le Tourneau T.

Eur Heart J. 2007 Feb;28(4):391. Epub 2006 Sep 11. No abstract available.

PMID:
16966342
34.

Frequency and characteristics of pancreatitis in patients with inflammatory bowel disease.

Barthet M, Lesavre N, Desplats S, Panuel M, Gasmi M, Bernard JP, Dagorn JC, Grimaud JC.

Pancreatology. 2006;6(5):464-71. Epub 2006 Jul 13.

PMID:
16847384
35.

p8 and prothymosin alpha: unity is strength.

Malicet C, Dagorn JC, Neira JL, Iovanna JL.

Cell Cycle. 2006 Apr;5(8):829-30. Epub 2006 Apr 17.

PMID:
16628001
36.

[Cystic fibrosis neonatal biology].

Sarles J, Dagorn JC.

Pathol Biol (Paris). 2006 May;54(5):263-5. Epub 2006 Mar 9. French. No abstract available.

PMID:
16527431
37.

Pancreatitis-associated protein I suppresses NF-kappa B activation through a JAK/STAT-mediated mechanism in epithelial cells.

Folch-Puy E, Granell S, Dagorn JC, Iovanna JL, Closa D.

J Immunol. 2006 Mar 15;176(6):3774-9.

38.

Regulation of apoptosis by the p8/prothymosin alpha complex.

Malicet C, Giroux V, Vasseur S, Dagorn JC, Neira JL, Iovanna JL.

Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2671-6. Epub 2006 Feb 14.

39.

p8 is a new target of gemcitabine in pancreatic cancer cells.

Giroux V, Malicet C, Barthet M, Gironella M, Archange C, Dagorn JC, Vasseur S, Iovanna JL.

Clin Cancer Res. 2006 Jan 1;12(1):235-41.

40.

Interaction of the stress protein p8 with Jab1 is required for Jab1-dependent p27 nuclear-to-cytoplasm translocation.

Malicet C, Hoffmeister A, Moreno S, Closa D, Dagorn JC, Vasseur S, Iovanna JL.

Biochem Biophys Res Commun. 2006 Jan 6;339(1):284-9. Epub 2005 Nov 15.

PMID:
16300740
41.

High-sensitivity C-reactive protein: potential adjunct for risk stratification in patients with stable congestive heart failure.

Lamblin N, Mouquet F, Hennache B, Dagorn J, Susen S, Bauters C, de Groote P.

Eur Heart J. 2005 Nov;26(21):2245-50. Epub 2005 Sep 23.

PMID:
16183690
42.

Combining immunoreactive trypsinogen and pancreatitis-associated protein assays, a method of newborn screening for cystic fibrosis that avoids DNA analysis.

Sarles J, Berthézène P, Le Louarn C, Somma C, Perini JM, Catheline M, Mirallié S, Luzet K, Roussey M, Farriaux JP, Berthelot J, Dagorn JC.

J Pediatr. 2005 Sep;147(3):302-5.

PMID:
16182665
43.

Prognostic significance of circulating levels of angiogenic cytokines in patients with congestive heart failure.

Lamblin N, Susen S, Dagorn J, Mouquet F, Jude B, Van Belle E, Bauters C, de Groote P.

Am Heart J. 2005 Jul;150(1):137-43.

PMID:
16084160
44.

TP53INP1 is a novel p73 target gene that induces cell cycle arrest and cell death by modulating p73 transcriptional activity.

Tomasini R, Seux M, Nowak J, Bontemps C, Carrier A, Dagorn JC, Pébusque MJ, Iovanna JL, Dusetti NJ.

Oncogene. 2005 Dec 8;24(55):8093-104.

PMID:
16044147
45.

Expression of mutated cationic trypsinogen reduces cellular viability in AR4-2J cells.

Gaiser S, Ahler A, Gundling F, Kruse ML, Savkovic V, Selig L, Teich N, Tomasini R, Dagorn JC, Mössner J, Keim V, Bödeker H.

Biochem Biophys Res Commun. 2005 Aug 26;334(2):721-8.

PMID:
16036133
46.

Inactivation of stress protein p8 increases murine carbon tetrachloride hepatotoxicity via preserved CYP2E1 activity.

Taïeb D, Malicet C, Garcia S, Rocchi P, Arnaud C, Dagorn JC, Iovanna JL, Vasseur S.

Hepatology. 2005 Jul;42(1):176-82.

PMID:
15962327
47.

The multifunctional family of secreted proteins containing a C-type lectin-like domain linked to a short N-terminal peptide.

Iovanna JL, Dagorn JC.

Biochim Biophys Acta. 2005 May 25;1723(1-3):8-18. Epub 2005 Jan 21. Review.

PMID:
15715980
48.
49.

Effects of bisoprolol in patients with stable congestive heart failure.

de Groote P, Delour P, Lamblin N, Dagorn J, Verkindère C, Tison E, Millaire A, Bauters C.

Ann Cardiol Angeiol (Paris). 2004 Jul;53(4):167-70.

PMID:
15369311
50.

Supplemental Content

Loading ...
Support Center